Hopkins Biotech Podcast

<p><b>Emily Gransky is the Vice President of Recruiting at </b><b>RA Ventures</b><b> (RAVen). RAVen is the early-stage venture arm of the multi-stage investment firm </b><b>RA Capital</b><b>. In this role, Emily works...

<p><b>Dr. Isaac Klein is the Chief Scientific Officer at </b><b>Dewpoint Therapeutics</b><b>. Dewpoint Therapeutics is leveraging condensate biology to impact a wide range of therapeutic targets across diverse disease...

<p><b>Dr. Adam Jenkins is the Regional Site Director for the Massachusetts sites of</b><b> Biolabs</b><b>. BioLabs is an international, membership-based network of shared lab and office facilities located in key biotech...

<p><b>In this episode, we talk with our panel about updates their company gave at the recent JP Morgan Healthcare Conference that took place earlier this year. This once-yearly conference is the epicenter for biotech...

<p><b>Brian Culley is the CEO of </b><b>Lineage Cell Therapeutics</b><b>, a clinical-stage biotech company whose mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with...

<p><b>In this episode, we talk with our panel about updates their company gave at the recent JP Morgan Healthcare Conference that took place earlier this year. This once-yearly conference is the epicenter for biotech...

<p><b>Adrian</b><b> is an advisor for several biotech companies in Argentina. Before joining </b><b>CITES</b><b>, a venture builder from Argentina, he worked as an advisor for RedCrow VC in San Francisco, and has more...

<p><b>Cyclacel Pharmaceuticals</b><b> is a clinical-stage, biopharmaceutical company, developing innovative cancer medicines based on cell cycle, transcriptional regulation, and mitosis biology with a focus on oncology...

<p>Radamés Cordero is the CEO of Melatech and an associate scientist and junior faculty in the department of Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health where he studies the...

<p><b> Ratio Therapeutics</b><b> is a Boston-based pharmaceutical company with the mission to accelerate the development of best-in-class targeted radiotherapeutics for the treatment of cancers. By employing a suite of...

<p><b>Dr. Anupam Chakravarty is a researcher whose research interests have straddled the disciplines of biochemistry and genomics with a keen focus on the biology of cancer. Currently, he is a senior scientist...

<p><b>Dr. Tony Russo Ph.D. is the Chairman, CEO, and founder of </b><b>Russo Partners</b><b>, a leading public and investor relations firm. He has been a member of the healthcare and technology PR and IR community for...

<p><b>Dr. Robert Hollingsworth is the current Chief Scientific Officer of </b><b>Shoreline Biosciences</b><b>, a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent...

<p><b>Dr. Shelley Ackerman is an Associate Director & Program Team Lead at </b><b>Bolt Biotherapeutics</b><b>. Bolt is a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine...

<p> Dr. James Coates is currently the Principal for Health & Human Performance at Decisive Point, an East coast venture capital firm that invests in and supports startups with deep tech and government use cases. James...